Современная тактика профилактики и лечения инфекций у больных раком пищевода
Диссертация
Одну из наиболее серьезных проблем для стационара любого профиля представляют инфекции, вызванные синегнойной. палочкой. Этот микроорганизм является наиболее частым возбудителем нозокомиальных инфекций среди всех грамотрицательных палочек. В' 16% случаев Р. aeruginosa является этиологическим инфекций дыхательных путей, в. 12%* случаев — инфекций, мочевыводящих путей- в 8% случаев возбудителем… Читать ещё >
Список литературы
- Брискин Б.С., Хачатрян Н. Н., Сосновикова О. Г. Опыт применения аугментина (амоксициллин/клавуланата) в хирургической клинике // Антибиотики и химиотерапия. -М. 2000. — № 45. — С. 4 — 6.
- Гостищев В.К. Рациональные подходы к профилактике инфекционных осложнений в хирургии // Методические рекомендации. Москва. 1997. С. 41.
- Давыдов М.И. Одномоментные операции в хирургическом и комбинированном лечении рака пищевода. Дисс. Доктора мед. наук, Москва, 1988 г.
- Дмитриева Н.В. Применение клиндамицина при профилактике и лечении инфекционных осложнений в онкологической клинике // Антибиотики и химиотерапия. Москва. 1994. — № 2 — 3. — С.52 — 56.
- Дмитриева Н.В., Петухова И. Н., Багирова Н. С. и др. Резистентность микроорганизмов — возбудителей инфекции у онкологических больных // Сопроводительная терапия в онкологии. Москва. — 2005. № 1. С. 17−25.
- Коротяев А, Бабичев С."Медицинская микробиология" // Москва. 1998. — С.528.
- Петухова И.Н. Антибиотикопрофилактика послеоперационных раневых инфекций // Сопроводительная терапия в онкологии. Москва. 2005. № 1. -С. 2−10.
- Сидоренко С.В. Клиническое значение Pseudomonas aeruginisa. Клиническая фармакология и терапия // Москва. 2003. — № 2. — С. 1−7.
- Стилиди И.С. Стратегия хирургии рака пищевода // Дисс. .докт. Мед. Наук. Москва. 2002. — С. 282.
- Страчунский Л.С., Козлов Р. С. Антибиотикопрофилактика в хирургии: взгляд клинического фармаколога // В сб: Рациональные подходы к профилактике инфекционных осложнений в хирургии. Москва. 1997. -С.12−21.
- Трапезников Н.Н., Аксель Е. М. Статистика злокачественных новообразований в России и странах СНГ. Москва. 2001 г., с.295
- Фомина И.П., Смирнова Л. Б., Гельфанд Е. Б. Антибиотики в профилактике хирургической инфекции (микробиологические и клинические аспекты) // Антибиотики и химиотерапия. Москва. 1998. — № 9. С. 35 — 43.
- Шевола Д., Дмитриева Н. В. Антибиотикопрофилактика в медицинской практике // Москва, 1999. — С. 128.
- Яковлев С.В. Схемы антибактериальной профилактики инфекционных осложнений в хирургии // Клиническая антимикробная химиотерапия. Москва. 1999. — т. 1, N1. — С. 32−34.
- Allen R. С. Phagocytic leukocyte oxygenation activities and chemiluminescence: a kinetic approach to analysis // Meth. Enzym. 1984. — v. 133.- p. 449−493.
- AltorkiN.K., Girardi L., Skinner D. Extended Resections for Carcinoma of the Thoracic Esophagus and Cardia // Recent Advances in Diseases of the Esophagus/ Eds. Peracchia A. Monduzzi Ed. Selected Papers of the 6th World Congress of the ISDE.- 1995.
- Altorki N.K., Migliore M., Skinner D.B. Esophageal cancer with airway obstruction. Evolution and choices of therapy. Chest 1994 Sep- 106(3): 742 — 3.
- Ang B.S., Telenti A., King В., Steckelberg J.M., Wilson W.R. Candidemia from a urinary tract source- microbiological aspects and clinical significance // Clin. Infect. Dis. -1991.-p. 75: 391.
- Arnaud J., Bellisant E., Boissel P. et al. Single-dose amoxycillin-clavulanic acid vs. cefotetan for prophylaxis in elective colorectal surgery: a multicentre, prosprctive randomized study. J. Hosp. Infect. 1992, 22 (Suppl. A): 23 33.
- Babior B.M. NADPH oxidase: an update. Blood
- Beck D.E., Wexner S.D. Fundamentals of anorectal surgery // McGraw-Hill, inc., 1992, p. 509.
- Bergen G., Shelhamer J. Pulmonary infiltrates in the cancer patient. Infect. Dis. Clin. North. Am., 1996, 10, 297−326.
- Blair S.L., Schwarz R.E. Critical Care of Patients with Cancer. Critical Care Clinics, 2001, v.7., N 3, pp.1−19.
- Bonenkamp J.J., Hermans J., Sasako M., Can de Velde С.J.H. for the Dutch Gastric Cancer Group. Extended lymph-node dissection for gastric cancer. // New Engl. J. Med. — 1999. — Vol. 340. — № 12. — P. 908 — 914.
- Bonfiglio G., Lacsai Y., Franceshini N., et al. In vitro activity of piperacillin/tazobactam against 615 Pseudomonas aeruginisa srains isolated in intensive care units. Chemotherapy, 1998,44, 305−312.
- Bozzetti F., Bignami P., Bertario L. et al. Surgical treatment of gastric cancer invading the oesophagus. // Europ. J. of Surg. Oncol. — 2000. — Vol. 26. — P. 810 — 814.
- Campillo F., Rubio J.M. Comparative study of single-dose cefotacsime and multiple doses of cefoxitin and cefazolin as prophylaxis in gynecologic surgery // Am J Surg. 1992 Oct, 164 (4 A Suppl.), 12 S 15 S.
- Carlet J. et al. Corticotherapy and serious infection. 2004. — 564.
- Cecconello I., Sallum R.A., Felix V.N. et al. Complications after resection of adenocarcinoma of the gastroesophageal junction // 5th Inernational Gastric Cancer Cogress. -Rome, Abstracts, 2003. — 61 p.
- Charlene K.M., Steven H.S., Mark P.P. et al., Multivariate Analysis of Factors Associated With Postoperative Pulmonary Complications Following General Elective Surgery // Arch Surg. 1998. — 133: 194 — 198.
- Christopher E.A., Patrick A.F., Gerard A.S. et al., Pulmonary Complications After Esophagectomy // Ann Thorac Surg. 2002. — 73: 922 — 926.
- Clark R.A. Activation of the neutrophil respiratory burst oxidase // J. Inf. Dis. 1999. — v. 179. — suppl. 2. — P. S 309 -17.
- Classen D.C., Evans R.S., Pestotnik S.L. et al. The timing of prophylactic administration of antibiotics and risk of surgical wound infection // N Engl J Med, 1992. V.326. — P.281−6.
- Collard J.M. Exclusive radical surgery for esophageal adenocarcinoma // Cancer.- 2001.-Vol.91.- P.1098−1104.
- Craven D.E., Steger K.A. Hospital-acquired pneumonia. Perspectives for the healthcare epidemiologist. Infect Control Hosp Epidemiol, 1997- 18:783−95.
- Damhuis R.A., Tilanus H.W. The influence of age on resection rates and postoperative mortality in 2773 patients with gastric cancer. // Eur. J. Cancer. — 1995. — Vol. 31 (6). — P. 928 — 931.
- Doty^ J. R., Salazar, J. D., Forastiere, A. A., Heath, E. I., Kleinberg, L., Heitmiller, R. F. Postesophagectomy morbidity, mortality, and length of hospital stay after preoperative chemoradiation therapy // Arm. Thorac. Surg 2002 -Vol.74.-P.227−231.
- Duignan JP, Collins PB, Johnson AH, Bouchier-Hayes D. The association of impaired neutrophil chemotaxis with postoperative surgical sepsis. // Br. J. Surg. -1986.-V. 73(3). -P|.238−40.
- Ehrenkrantz N.J. Antimicrobial prophilaxis in surdgery: mechanism, misconceptions, snd mischiefs//Infect. Control. Hosp. Epidemiol. 1993. — 14: 99 -106.
- Entwistle, J. W.C. Ill, Goldberg, M. (). Multimodality therapy for resectable cancer of the thoracic esophagus // Ann. Thorac. Surg. 2002.- Vol.73.- P. 10 091 015.
- Finberg R.W. Infection in cancer patients // Cancer Medicine and Hematology. Harvard Medical Shool Department of Continuing Education. -October 26. 1999.
- Geroulanos J., Stern A., Christen D., Bouchmann P. Management of postoperative abdominal infections: single vs combination therapy//Infect. Surg. — 1990. 9 (Suppl. 1): 65−8.
- Giacometti A., Cirioni O., Schimizzi A.M., et al. Epidemiological surveillance of surgical wound infections // In: 3-rd Intern Meeting on the Therapy of Infections. Florence. Italy. — Dec.4−6. — 2000. — Abstr. В 40.
- Giamarellou H., Antoniadou A. Infectiouns complications of febrile leukopenia. Infections in the compromised host //Inf. Dis. Clin, of N Am. 2001. — 15(2):457 — 482.
- Gilbert D.N., Moellering R.C., Sande M.A. The Sanford Guide to Antimicrobial Therapy. 38-th Edition. 1998. -p.53.
- Glauser M. P,.Pizzo P. A Menagement of Infections in Immunocompromised Patients.-p. 125, 2000.
- Gordon S., Serkey J., Keys T. et al. Secular trends in nosocomial bloodstream infections in 55-bed cardiothoracic intensive care unit // Ann. Thorac. Surg. — 1998.-65.-95- 100.
- Griffin S.M., Shaw I.H., Dresner S.M. Early Complications after Ivor Lewis Subtotal Esophagectomy with Tho-Field Lymphadenectomy: Risk Faktors and Management//О Am Coll Surg. -2002. -194: 285 297.
- Isono K., Ochiai Т., Koide Y. More or less surgery for esophageal cancer, indications for extended three-field Lymphadenectomy for esophageal cancer. Dis Esophagus 1994- 7: 147−150.
- Gudiol F. Principles of surgical prophylaxis: Tradition and Change // In: Workbook of Symp. The clinical Management of infectious diseases. Spain. -Nov. 6−8.-1997.-P. 52−53.
- Gyssens L.C., Knape J.T.A., van der Meer J.W.M., et al. The Anaesthesist as Determinant Factor of Quality of Antimicrobial Prophylaxis in Surgery // 7-th Eur Congr Clin Microbiol Infect Dis. Vienna. Austria. -1995. — March. — 26−30 -Abstr.1250.
- Hampton M.B., Kettle A. J. and Winterbourn C.C. Inside the neutrophil phagosome: oxidants, myeloperoxidase and bacterial killing //Blood. 1998. — v. 92 (9).-P. 3007−3017.
- Hemsell D.L., Martin J.N., Pastorek J.G. II, et al. Single-dose Antimicrobial Prophylaxis at Abdominal Hysterectomy: Cefamandole vs. Cefotaxime // J Reproduct Med. 1988. — V.33, N12. — P.939−944.
- Higgins A., London J., Charland S. et al. Prophylactic antibiotics for elective laparoscopic cholecystectomy: are they necessary? // Arch Surg. 1999. — Jun. -134(6): 611−3.
- Hulscher J.B.F., Tijssen J.G.P., Obertop H., van Lanschot J.J.B. Transthoracic versus transhiatal resection for carcinoma of the esophagus: a meta-analysis // Ann Thorac Surg.- 2001.-Vol.72.- № 1.- P.306−313.
- Hyunjoo Pai, Jong-Won Kim, Jungmin Kim, Hyang Lee, Kang Naomasa Gotoh. Carbapenem Resistance Mechanisms in Pseudomonas aeruginisa Isolets // Antimicrob Agents Chemother. 2001. — Feb. — 45 (2). — 480 — 484.
- Ibrahim N.K., Sahin A.A., Dubrow R.A., Lynch P.M., Boehnke-Michaud L., Valero V., Busdar A.U., Hortobagyi G.N. Colitis associated with docetaxel-basedchemotherary in patients with metastatic breast cancer // Lancet. 2000. -355(9200):281 -283.
- Jeffrey H. Silber, Paul R. Rosenbaum, Martha E. Trudeau et al. Preoperative antibiotics and Mortality in the Elderly // Ann of Sur. 2005. — 242 (1): 107 — 114.
- Jones R.N., Wojeski W.V. Single-dose cephalosporin prophylaxis of 929 surgical procedures in a prepaid group practice: a prospective, randomized comparison of cefoperazone and cefotaxime // Diagn Microbiol Infect Dis. 1987. -Apr.- 6(4): 323−34.
- Juan A.C., Claude D., Stephen D. et al. Selective management of intrathoracic anastomotic leak esophagectomy // J of Thoracic and Cardiovascular Surgery. -2005.-Fev.- 12(2): 345−348.
- Kato H. Lymph Node Dissection for Thoracic Esophageal Carcinoma. Two-and Three-field Lymph Node Dissection. Annales Chirurgiae et Gynaecologiae- 1995, 84(2): 193−9.
- Kellum J.M., Gargano S., Gorbach S.L., Talcof C., Curtis L.E. et al. Antibiotic prophylaxis in high-risk biliary operations: multicenter trial of single preoperative ceftriaxone versus multidose cefasolin // Am J Surg. 1984. — Oct 19. — 148 (4A): 15−8.
- Kluytmans J. Surgical infections including burns. In: Wenzel R. (ed). Prevention and control of nosocomial infections//Williams and Wilkins. 1997. -841−865.
- Koozeniowski O.M. Urinary tract infections in the impaired host //Med. Clin. N Am.-1991. -75:391.
- Kow L., Toouli J., Brookman J., McDonald P.J. Comparison of cefotaxime plus metronidazole versus cefoxitin for prevention of wound infection after abdominal surgery // World J Surg 1995 Sep Oct 19 (5): 680 — 6.
- Lars Tue Sorenses, Ulla Hemmingsen, Flinn Kallehave et al., Risk Factors for Tissue Wound Complications in Gastrointestinal Surgery // Ann of Sur. 2005. -241: 654−658.
- Leather H.L., Wingard J.R. Infections following hematopoietic stem cell transplantation. Infections in the compromised host // Inf. Dis. Clin, of N Am. -2001.- 15(2):487−520.
- Livermore D. Beta-lactamases in laboratory and clinical resistance // Clin. Microbiol. Rev. 1995. — 8. — 557 — 584.
- Lohde E., Muller S., Luck M., et al. Analysis of Risk Factors for Postoperative Infectious Complications // In: Recent advances in Chemotherapy. Proc 18-th Intern Congr Chemother, 1993. P. 728−729.
- Lowry F.D., Carlisle P. S., Adams A., Feiner C. The incidence of nosocomial pneumonia following urgent endotracheal intubations // Infect. Control. 1987. -8(6):245 — 248.
- Luketich J.D., Alvelo-Rivera M., Buenaventura P.O. et. al. Minimally invasive esophagectomy: outcomes in 222 patients //Ann Surg.-2003.- Vol.238.-№ 4.- P.486−494.
- Mancuso S., Oliva G. A long- acting cephalosporins in short-term prophylaxis in obstetric and gynecologic surgery // Eur. Surgical Res. (World Congr. Inter. College of Surgeons, Milan, July 3−9, 1988). 1991. — 21 (Suppl. 1): 19 — 25.
- Mayer H.O., Pertu E., Haas J., Heydarfadai M. Perioperative antibiotic prophilaxis in patients undergoing radical surgery for gynecological cancer: single dose versus multiple dose administration // Eur. J. Gynecol. Oncol. 1993. — 14 (3): 177−81.
- McDonald M., Grabsch E., Marshall C., et al. Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review // Aust N Z J Surg, 1998.-V.68.-P.388—396.
- Mims C., Playfair J., Roitt I., Wakelin D., Williams R. Medical microbiology. Mosby. — Edinburg. — 2002. — 584.
- Morris J.S., Meakins J.L., Christou N.V. In vivo neutrophil delivery to inflammatory sites in surgical patients. Correlation with in vitro neutrophil chemotaxis and adherence//Arch. Surg. 1985. — v. 120(2). — P.205−9.
- Nichols R.L. Surgical antibiotic prophylaxis // Med Clin North Am. 1995. -V.79. — N3.-509−522.
- Nomura S., Sasako M., Katai H. et al. Decreasing complication rates with stapled esophagoejunostomy following a learning curve. // Gastric Cancer. — 2000.—Vol. 3. —P. 97 — 101.
- Novelli A. Antimicrobial Prophylaxis in Surgery: the Role of Pharmacokinetics // J Chemother. 1999. — V. l 1, Suppl.2. — p.56.
- Pearson F.G., Deslauriers J., Ginsberg R.J., Hiebert C.A., McKneally M.F., Urschel H.C. Esophageal Surgery // Churchill Livingstone Inc. 1995.- P.761−774
- PeracchiaA., Bonavina L., Incarbone R., Floridi A. Results of surgical therapy in patients with adenocarcinoma of the esophagus and cardia. // Gastric Cancer. — 1999. — Vol. 2. — P. 89 — 94.
- Pollack M. Pseudomonas aeruginisa. In: Mandell G., Benett J., Dolin R.theds.) Principles and practice of infectious diseases. 4 ed. New York: Churchill Livingstone. 1995. — 1980 — 2003.
- Poole K., Krebes K., McNally C., Neshat S. Multiple antibiotics resistance in Pseudomonas aeruginisa: evidence for involvement of an efflux operone // J. Bacteriol. 1993. — 175. — 7363 — 7372.
- Rahamim J.S., Murphy G.J., Awan Y., Junemann-Ramirez M. The effect of age on the outcome of surgical treatment for carcinoma of the oesophagus and gastric cardia. // Eur. J. Cardiothorac. Surg. — 2003. — Vol. 23(5). — P. 805 — 810.
- Rahamim J.S., Murphy G.J., Awan Y., Junemann-Ramirez M. The effect of age on the outcome of surgical treatment for carcinoma of the oesophagus and gastric cardia. // Eur. J. Cardiothorac. Surg. — 2003. — Vol. 23(5). — P. 805 — 810.
- Reid P.T., Donnelly S.C., MacGregor Y.R. Pulmonary endothelial permeability and circulating neutrophil-endothelial marces in patients undergoing esophagogastrectomy // Crit Care Med. 2000. — Sep. — 29 (9): 3354 — 5.
- Rungtip Chuanchuen, Craig T. Narasaki, Herbert P. Schweizer. The MexJK Efflux Pump of Pseudomonas aeruginisa Req Antibiotic Efflux but Not for Efflux of Triclosan // J. Bacteriol. 2002. — Sep. — 184 (18): 5036 — 5044.
- Sato Т., Sakai Y., Kojita A. Radiographic microstructures of early esophageal carcinoma: correlation of specimen radiography with pathologic findings and clinical radiography. Gastrointestinal Radiology- 1986, 11: 12−19.
- Saito Т., Shigemitsu Y., Kinoshita Т., Shimoda K., Miyahara M., Kobayashi M. Impaired neutrophil bactericidal activity correlates with the infection occurring after surgery for esophageal cancer. J. Surg.Oncol. — 1992. — v.51(3). — P. 159−63.
- Sarmiento J.M., Sarr M.G. Necrotic infected liver metastasis from colon cancer // Surgery. 2002. — Vol. 132. (1). — P. 110 — 111.
- Sasako M. Surgical management of gastric cancer: the Japanese experience. // III Workshop of who-collaborating- center for gastric cancer in cooperation with N.N. Blokhin Russian Cancer Rasearch Center, Moscow. — 2003. — P. 107 — 122.
- Scaglione F. Pharmacotherapy the Facts and Fantasies of Prophylaxis and Combined Therapies // Eur J Surg, 1997. — Suppl.578. — pp.11−15.
- Scevola D. La profilassi antibiotico nella practica chirurgica e medica. // Edizioni Micom s.r.l. 1998. — 128 p.
- Scher K.S. Studies on the duration of antibiotic administration for surgical prophylaxis // Am Surg, 1997. V.63. — pp.59−62.
- Schiffman E.J. Hematologic Pathophysiology. 2001. — Lippincott-Raven Publishers Philadelphia-New York. — p. 138.
- Schimpff S.C. Infections in the cancer patients. Diagnosis, prevention and treatment. In: Principles and practice of infectious Diseases G.L. Mandell, J.E. Benneth, R. Dolin (eds). New York: Churchill Livingstone. — 1995. — P. 2666 -2675.
- Schmidt R.F., Thews G. Human Physiology // Springer-Verlang Berlin Heidelberg. 1989. — 640. — 427 — 428.
- Segal H.B., Walsh Т.J., Holland S.M. Infections in the cancer patient. In: De Vita VT Jr, Hellman S., Rosenberg S.A., eds. Cancer Principles and Practice of Oncology. 6th ed. Philadelphia: Lippincott Williams and Wilkins. 2001:32 855 -2858.
- Serody J.S., Shea T.C. Prevention of infections in bone marrow transplant recipients. Nosocomial Infections //Inf. Dis. Clin. Of N Am. 1997. — 2(2):459 -477.
- Shimada K., Noro Т., Inamatsu Т., et al., Bacteriology of acute obstructive suppurative cholangitis of the aged//О J Clin Microbiol. 1981. — 14:552−526.
- Shimusu J., Kinoshita Т., Tatsuzawa Y. et al. Gluteal abscess caused by perforating rectal cancer: case report and review of the literature. // Tumors. -2001.-Vol. 87(5).-P. 330−331.
- Siewert J.R., Feith M., Wenner M. et al. Adenocarcinoma of the esophagogastric junction. Results of surgical therapy based on anatomical/topographic classification in 1002 consecutive patients // Ann. Surg. — 2000. — Vol. 232(3). — P. 353 — 361.
- Stamm W.E., The Epidemology of Urinary Tract Infections .-Risk Factors Reconsidered // 39-th ICAAC. Sept. 26−29. — 1999. — San Francisco. -California. — USA.- Abstr.1353.
- Taylor E.W. Surgical infection: Current Concerns // Eur. J. Surg. 1997. -163 (Suppl. 578):5 — 9.
- Thilo Kohler, Mehri Michea-Hamzehpour, Simone F. Carbapenem Activities against Pseudomonas aeruginisa: R Contributions of OprD and Efflux Systems I I Antimicrob Agents Chemother. 1999. — Feb. — 43 (2): 424 — 427.
- Tramont C.E., Hoover D.L. Innate (general or non-specific) host defense mechanisms // Basic Principles in the Diagnosis and Managementof Infectious dieases. Vol.1. — 5th ed. Philadelphia: Churchill-Livingstone. — 2000:31.
- Turano A. New clinical data on the prophylaxis of infections in abdominal, gynecologic, and urologic surgery. Multicenter Study Group // Am J Surg. 1992 Oct.- 164 (4 A), 16S-20S.
- Uchiyama К., Kawai M., Onishi H., Tani M. et al. Preoperative antimicrobial administration for prevention of postoperative infection in patients with laparoscopic cholecystectomy // Dig Dis Sci. 2003. — Oct. — 48(10): 1955 — 9.
- Van Sandick W., Gisbertz S., Boermeester A. Immune Responses and Prediction of Major Infection in Patients Undergoing Transhiatal or Transthoracic Esophagectomy. Cancer Ann of Surg // 2003 Vol.- 237- 1. p. 35−43.
- Vincent A. L,.Greene J. N Infection Complication of Gastrointestinal Cancer. 222. — 2004.
- Viscoli C., Castagnola E., VanLint M.T. et al. Fluconasole versus amphothericin as empirical antifungal therapy of unexplained fever in granulocytpenic cancer patients // Eur J Cancer. -1996. 32A:814−820.
- Wiblin R. Nosocomial pneumonia. In: Wenzel R. (ed). Prevention and control of nosocomial infections // 3rd ed. Baltimore: Williams and Wilkins. 1997. — 807 -819.
- Willson A., Scrimpton S., Jaderberg M. A meta-analysis of the use of amoxicillin-clavulanic acid in surgical prophilaxis // J. Hosp. Infect. 1992. — 22 (Suppl. A): 9−23.